Dr Reddys Laboratories Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Consolidate Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Net Sales

8,828.30

8,572.10

8,528.40

8,381.20

8,038.20

7,696.10

7,113.80

Other Operating Income

0.00

Total Operating income

8,828.30

8,572.10

8,528.40

8,381.20

8,038.20

7,696.10

7,113.80

Raw Material Cost

1,441.30

2,035.80

1,716.50

1,452.60

1,287.20

1,227.20

1,096.20

Purchase of Finished goods

1,745.90

1,215.90

1,127.50

1,050.70

1,282.80

1,380.10

1,175.90

(Increase) / Decrease In Stocks

-63.50

-444.20

6.00

78.20

-203.30

-425.60

-180.00

Employee Cost

1,452.10

1,503.50

1,400.60

1,366.50

1,399.20

1,413.70

1,283.60

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

2,242.60

2,087.50

2,279.90

2,160.20

2,195.80

1,970.80

1,906.90

Total Expenditure (Excl Depreciation)

6,818.40

6,398.50

6,530.50

6,108.20

5,961.70

5,566.20

5,282.60

Operating Profit (PBDIT) excl Other Income

2,009.90

2,173.60

1,997.90

2,273.00

2,076.50

2,129.90

1,831.20

Other Income

323.90

290.30

522.10

150.20

307.50

187.20

197.50

Operating Profit (PBDIT)

2,333.80

2,463.90

2,520.00

2,423.20

2,384.00

2,317.10

2,028.70

Interest

90.70

83.00

65.60

81.70

75.70

59.80

59.30

Exceptional Items

0.00

Gross Profit (PBDT)

2,243.10

2,380.90

2,454.40

2,341.50

2,308.30

2,257.30

1,969.40

Depreciation

504.60

476.10

454.70

471.40

397.00

380.60

367.70

Profit Before Tax

1,744.80

1,905.00

2,005.20

1,874.30

1,917.40

1,882.60

1,605.20

Tax

408.00

495.10

418.50

470.10

575.50

490.20

295.40

Provisions and contingencies

0.00

Profit After Tax

1,330.50

1,409.70

1,581.20

1,400.00

1,335.80

1,386.50

1,306.30

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

1,330.50

1,409.70

1,581.20

1,400.00

1,335.80

1,386.50

1,306.30

Share in Profit of Associates

6.30

0.20

5.50

4.20

6.10

5.90

3.50

Minority Interest

-10.30

-8.20

-6.60

-9.50

86.20

0.00

Other related items

0.00

Consolidated Net Profit

1,347.10

1,418.10

1,593.30

1,413.70

1,255.70

1,392.40

1,309.80

Equity Capital

83.50

83.40

Face Value

1.0

5.0

Reserves

0.00

Earnings per share (EPS)

16.13

16.98

19.1

16.95

15.06

16.7

15.71

Diluted Earnings per share

16.18

17.02

19.1

16.94

15.05

16.7

15.71

Operating Profit Margin (Excl OI)

22.83%

25.44%

23.49%

27.19%

25.9%

27.76%

25.85%

Gross Profit Margin

25.48%

27.86%

28.85%

28.01%

28.8%

29.42%

27.8%

PAT Margin

15.18%

16.5%

18.65%

16.8%

16.74%

18.15%

18.49%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Sep 2025 is 2.99% vs 0.51% in Jun 2025

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is -5.01% vs -11.00% in Jun 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -7.53% vs 8.79% in Jun 2025

Interest

QoQ Growth in quarter ended Sep 2025 is 9.28% vs 26.52% in Jun 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Dr Reddy's Labs With

Select Peers

Figures in Cr

Consolidate Quarterly Results

Change(INR)

Change(%)

Net Sales

8,828.30

7,589.44

1,238.86

16.32%

Other Operating Income

0.00

Total Operating income

8,828.30

7,589.44

1,238.86

16.32%

Raw Material Cost

1,441.30

1,528.16

-86.86

-5.68%

Purchase of Finished goods

1,745.90

892.98

852.92

95.51%

(Increase) / Decrease In Stocks

-63.50

76.50

-140.00

-183.01%

Employee Cost

1,452.10

1,314.80

137.30

10.44%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

2,242.60

1,882.25

360.35

19.14%

Total Expenditure (Excl Depreciation)

6,818.40

5,694.69

1,123.71

19.73%

Operating Profit (PBDIT) excl Other Income

2,009.90

1,894.75

115.15

6.08%

Other Income

323.90

268.95

54.95

20.43%

Operating Profit (PBDIT)

2,333.80

2,163.70

170.10

7.86%

Interest

90.70

13.18

77.52

588.16%

Exceptional Items

0.00

Gross Profit (PBDT)

2,243.10

2,150.52

92.58

4.31%

Depreciation

504.60

296.99

207.61

69.90%

Profit Before Tax

1,744.80

1,853.53

-108.73

-5.87%

Tax

408.00

500.46

-92.46

-18.48%

Provisions and contingencies

0.00

Profit After Tax

1,330.50

1,353.07

-22.57

-1.67%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

1,330.50

1,353.07

-22.57

-1.67%

Share in Profit of Associates

6.30

0.30

6.00

2,000.00%

Minority Interest

-10.30

2.20

-12.50

-568.18%

Other related items

0.00

Consolidated Net Profit

1,347.10

1,351.17

-4.07

-0.30%

Equity Capital

83.50

161.55

-78.05

-48.31%

Face Value

1.00

2.00

0.00

Reserves

0.00

Earnings per share (EPS)

16.13

16.73

-0.60

-3.59%

Diluted Earnings per share

16.18

16.72

-0.54

-3.23%

Operating Profit Margin (Excl OI)

22.83%

25.44%

0.00

-2.61%

Gross Profit Margin

25.48%

28.88%

0.00

-3.40%

PAT Margin

15.18%

18.17%

0.00

-2.99%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 8,828.30 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 2.99% vs 0.51% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 9.83% vs 16.45% in Sep 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 1,347.10 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -5.01% vs -11.00% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 7.28% vs -15.28% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 2,009.90 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -7.53% vs 8.79% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -3.21% vs 3.40% in Sep 2024

Quarterly - Interest

Interest 90.70 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 9.28% vs 26.52% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 19.82% vs 114.45% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 22.83%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024